---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-053039"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2021-11-01T23:59:59+00:00"
generated_at: "2026-06-28T15:38:55.029068+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# EyePoint appoints Jay S. Duker as COO; $500K base, 305K options

## Summary
- Appointed Jay S. Duker, M.D. as COO effective Nov. 1, 2021; he had served as part-time Chief Strategic Scientific Officer since July 2020.
- Annual base salary of $500,000; eligible for target annual bonus of 50% of base salary based on performance.
- Granted options to purchase 305,000 shares at $11.47, vesting over 4 years; received 15,258 RSUs valued at $175,000 vesting in 1 year.
- Received one-time cash award of $175,000 subject to repayment if terminated for cause within one year.
- Dr. Duker previously chaired ophthalmology at Tufts Medical Center and co-founded three start-ups including Hemera Biosciences.

## SEC filing metadata
- accession: 0001564590-21-053039
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2021-11-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000156459021053039/0001564590-21-053039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000156459021053039/eypt-8k_20211101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-053039
- JSON: https://secwatch.observer/filing/0001564590-21-053039.json
- Plain text: https://secwatch.observer/filing/0001564590-21-053039.txt

## Key facts
- Executive change
  Jay S. Duker was appointed as Chief Operating Officer at EyePoint, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On November 1, 2021 (the “ COO Start Date ”), EyePoint Pharmaceuticals , Inc. (the “ Company ”) announced that the Board of Directors (the “ Board ”) of the Company appointed Jay S. Duker, M.D., age 63, as the Company's Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1314102/000156459021053039/0001564590-21-053039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.